Photodynamic therapy and digital angiography of experimental iris neovascularization using liposomal benzoporphyrin derivative

Ophthalmology

Volumn 104, Issue 8, 1997, Pages 1242-1250

  Husain, D ^a   Miller, J W ^a   Kenney, A G ^a   Michaud, N ^a   Flotte, T J ^a   Gragoudas, E S ^a  

^a MASSACHUSETTS EYE AND EAR INFIRMARY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; FLUORESCEIN SODIUM; INDOCYANINE GREEN;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIGITAL SUBTRACTION ANGIOGRAPHY; DRUG EFFICACY; FLUORESCENCE ANGIOGRAPHY; HISTOPATHOLOGY; INTRAVENOUS DRUG ADMINISTRATION; IRIS BLOOD VESSEL; IRIS DISEASE; MONKEY; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

EID: 0031472966     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-6420(97)30151-1     Document Type: Article

References (30)

1. S Gartner P Henkind Neovascularization of the iris (rubeosis iridis) Surv Ophthalmol 22 1978 291 312
2. JW Miller AP Adamis DT Shima Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model Am J Pathol 145 1994 574 584
3. PA Adamis DT Shima MJ Tolentino Inhibition of vascular endothelial growth factor prevents retinal ischemia-associated iris neovascularization in a nonhuman primate Arch Ophthalmol 114 1996 66 71
4. DT Shima A Gougos JW Miller Cloning and mRNA expression of vascular endothelial growth factor in ischemic retinas of Macaca fascicularis Invest Ophthalmol Vis Sci 37 1996 1334 1340
5. LP Aiello RL Avery PG Arrigg Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders N Engl J Med 331 1994 1480 1487
6. CJ Pournaras Retinal oxygen distribution. Its role in the physiopathology of vasoproliferative microangiopathies Retina 15 1995 332 347
7. BM Glaser Extracellular modulating factors and the control of intraocular neovascularization. An overview Arch Ophthalmol 106 1988 603 607
8. M Wand DK Dueker LM Aiello WM Grant Effects of panretinal photocoagulation on rubeosis iridis, angle neovascularization, and neovascular glaucoma Am J Ophthalmol 86 1978 332 339
9. MJ Manyak A Russo PD Smith E Glatstein Photodynamic therapy J Clin Oncol 6 1988 380 391
10. CHM Jamieson WN McDonald JG Levy Preferential uptake of benzoporphyrin derivative by leukemic versus normal cells Leuk Res 14 1990 209 219
11. CJ Gomer Photodynamic therapy in the treatment of malignancies Semin Hematol 26 1989 27 34
12. C Zhou New trends in photobiology: mechanisms of tumor necrosis induced by photodynamic therapy J Photochem Photobiol B 63 1989 87 93
13. B Aveline T Hasan RW Redmond Photophysical and photosensitizing properties of benzoporphyrin derivative monoacid ring A (BPD-MA) Photochem Photobiol 59 1994 328 335
14. AM Richter E Waterfield AK Jain Photosensitising potency of structural analogues of benzoporphyrin derivative (BPD) in a mouse tumour model Br J Cancer 63 1991 87 93
15. JS Nelson LH Liaw A Orenstein Mechanism of tumor destruction following photodynamic therapy with hematoporphyrin derivative, chlorin, and phthalocyanine J Natl Cancer Inst 80 1988 1599 1605
16. G Jori E Reddi I Cozzani L Tomio Controlled targeting of different subcellular sites by porphyrins in tumour-bearing mice Br J Cancer 53 1986 615 621
17. J Lui L Hruza N Kollias Photodynamic therapy of malignant skin tumors with benzoporphyrin derivative monoacid ring A (BPD-MA): preliminary investigations chairs/editors R Rox Anderson Proceedings of Lasers in Otolaryngology, Dermatology, and Tissue Welding: 16-18 January 1993, Los Angeles, CA. (Progress in biomedical optics; Proceedings of SPIE; v.1876) 1993 SPIE Bellingham, Washington 147 151
18. JW Miller AW Walsh M Kramer Photodynamic therapy of experimental choroidal neovascularization using lipoprotein-delivered benzoporphyrin Arch Ophthalmol 113 1995 810 818
19. AJ Packer DT Tse X-Q Gu Hematoporphyrin photoradiation therapy for iris neovascularization Arch Ophthalmol 102 1984 1193 1197
20. JW Miller WG Stinson WA Gregory Phthalocyanine photodynamic therapy of experimental iris neovascularization Ophthalmology 98 1991 1711 1719
21. M Kramer JW Miller N Michaud Liposomal benzoporphyrin derivative verteporfin photodynamic therapy: selective treatment of choroidal neovascularization in monkeys Ophthalmology 103 1996 427 438
22. D Husain JW Miller N Michaud Intravenous infusion of liposomal benzoporphyrin verteporfin for photodynamic therapy of experimental choroidal neovascularization Arch Ophthalmol 114 1996 978 985
23. LH Young MA Howard LK Hu Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative Arch Ophthalmol 114 1996 186 192
24. AM Richter S Cerruti-Sola ED Sternberg Biodistribution of tritiated benzoporphyrin derivative (3H-BPDMA), a new potent photosensitizer, in normal and tumorbearing mice J Photochem Photobiol B 5 1990 231 244
25. AM Richter E Waterfield AK Jain Liposomal delivery of a photosensitizer, benzoporphyrin derivative monoacid ring A (BPD) to tumor tissue in a mouse tumor model Photochem Photobiol 57 1993 1000 1006
26. SA D'Anna BF Hochheimer HC Joondeph KE Graebner Fluorescein angiography of the heavily pigmented iris and new dyes for iris angiography Arch Ophthalmol 101 1983 289 293
27. R Brancato F Bandello R Lattanzio Indocyanine green iris angiography Atlas of Iris Fluorescein Angiography 1995 Kugler and Ghedini New York 68 71
28. RC Benson HA Kues Fluorescence properties of indocyanine green as related to angiography Phys Med Biol 23 1978 159 163
29. MJ Tolentino JW Miller ES Gragoudas Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate Arch Ophthalmol 114 1996 964 970
30. R Brancato F Bandello R Lattanzio Normal fluorescein angiography Atlas of Iris Fluorescein Angiography 1995 Kugler and Ghedini New York 33 34